Cited by 88Sepsis Diagnosis and TreatmentLipoproteins and Cardiovascular HealthHyperglycemia and glycemic control in critically ill and hospitalized patients

Reduction in Mortality Associated with Statin Therapy in Patients with Severe Sepsis

Dobesh, Paul P., Klepser, Donald G., McGuire, Timothy R., Morgan, Craig W., Olsen, Keith M.·2009·Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Abstract

Study Objective. To evaluate the effect of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors (statins) on mortality in patients with severe sepsis. Design. Retrospective cohort study. Setting. Intensive care unit (ICU) of an academic medical center. Patients. One hundred eighty‐eight patients aged 40 years or older with a diagnosis of severe sepsis and an ICU stay between January 1, 2005, and December 31, 2006. Measurements and Main Results. Patient demographic data, statin use, and Acute Physiology and Chronic Health Evaluation (APACHE) II scores at the time of sepsis diagnosis were collected from the patient database. We used a multivariable logistic regression model to evaluate the association between statin use and in‐hospital all‐cause mortality after controlling for age, sex, and severity of illness. Of the 188 patients who met our inclusion criteria, 60 (32%) had statin exposure. Patients receiving statins were similar in age, sex, and APACHE II scores to those not receiving statins. In the univariable comparison, the statin group had a 35% relative reduction in mortality compared with the nonstatin group (mortality rate 31.7% vs 48.4%, p=0.040). Most of the mortality reduction attributed to statins occurred in patients with APACHE II scores higher than 24 (mortality rate 32.3% vs 57.5%, p=0.031), with a minimal mortality difference in patients with APACHE II scores of 24 or lower (31% vs 36.4%, p=0.810). In the multivariable regression model, statin use had a protective effect (odds ratio [OR] 0.42, 95% confidence interval [CI] 0.21‐0.84, p=0.014), whereas increasing age (OR 1.03, 95% CI 1.01‐1.06, p=0.013) and higher APACHE II score (OR 1.11, 95% CI 1.05‐1.18, p=0.001) were associated with increased mortality. Conclusion. The use of statins was associated with a protective effect in patients with severe sepsis, as demonstrated by a significant reduction in mortality compared with patients not receiving statins.

Integrity signals

Registry

Crossref · 10.1592/phco.29.6.621

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

The citation lists haven’t been fetched yet

References 35 · Cited by 88

Authors
Dobesh, P. P., Klepser, D. G., McGuire, T. R., Morgan, C. W., & Olsen, K. M.
Affiliations
University of Nebraska Medical Center (US)
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
2009-06
Volume
29
Issue
6
Pages
621-630
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W2108520218
Cited by
88
References
35
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 13 · 2013: 7 · 2012: 4
FWCI
6.49
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Keywords
statins, severe sepsis, mortality, APACHE II score, intensive care unit patients, in-hospital mortality, age as risk factor, sepsis severity, age-adjusted mortality, mortality risk factors
MeSH terms
Academic Medical Centers, Adult, Critical Care, Female, Humans, Inflammation, Intensive Care Units, Male, Nebraska, Severity of Illness Index, Logistic Models, Case-Control Studies, Databases, Factual, Sepsis, APACHE, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review